From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Why I stay short of Avocet

By Lucian Miers | Thursday 3 November 2016


Disclosure: The author has a short position in one or more of the shares mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I see that Avocet Mining (AVM) which I warned in May and August this year imploded the other day as it admitted that insolvency could be looming. If, like Xcite (XEL), about which I wrote the other day, it does enter administration, the shares are still a compelling sell. This, I believe is by far the most likely outcome and I stay short. The company's words in the recent statement are explicit:


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 09:03:45